2026 NPPES data Colon & Rectal Surgery Physician NPI 1386888147 M.D.
Verify on CMS →

SHOHRAT ANNABERDYEV, M.D.

Colon & Rectal Surgery Physician in ROSEVILLE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
181
Medicare Part D claims · 68 beneficiaries · Colon & Rectal Surgery Physician avg: 196
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.0K
8 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SHOHRAT ANNABERDYEV, M.D. filed 181 Medicare Part D claims in 2023 as a Colon & Rectal Surgery Physician in ROSEVILLE, California, prescribing 91% generic.

181
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SHOHRAT ANNABERDYEV, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

181 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

SHOHRAT ANNABERDYEV, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SHOHRAT ANNABERDYEV, M.D.?

Quality data not reported

NPI registry status

Active

Issued 04/23/2009

NPI 1386888147

Primary specialty

Colon & Rectal Surgery Physician

Niche

1,608 US NPIs in this specialty

Medicare Part D claims

181 8% vs specialty avg

2023 prescription claims

Specialty avg: 196

Specialty distribution in California

How Colon & Rectal Surgery Physician compares to other specialties among California providers

California providers

Colon & Rectal Surgery Physician share within California

1. Colon & Rectal Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Colon & Rectal Surgery Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Colon & Rectal Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Colon & Rectal Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Colon & Rectal Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Colon & Rectal Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHOHRAT ANNABERDYEV, M.D. appears in the CMS NPPES registry as a Colon & Rectal Surgery Physician provider holding M.D. credentials at 8 MEDICAL PLAZA DR STE 300, ROSEVILLE, CA, 95661, with a listed phone of (916) 755-7095. NPI 1386888147 was issued on 04/23/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ANNABERDYEV most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 181 prescription claims written by this provider, covering 68 Medicare beneficiaries and totaling roughly $4K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 26.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Colon & Rectal Surgery Physician is a narrow specialty nationwide, with 1,608 enrolled providers across 50 states and an average of 196 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8 MEDICAL PLAZA DR STE 300
ROSEVILLE, CA 95661

Provider Details

NPI 1386888147
Specialty Colon & Rectal Surgery Physician
Credentials M.D.
Gender Male
NPI Issued 04/23/2009

Hospital and facility affiliations

Facilities where SHOHRAT ANNABERDYEV, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SUTTER VALLEY MEDICAL FOUNDATION
ROSEVILLE, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SHOHRAT ANNABERDYEV, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$2.0K

Largest payer

INTUITIVE SURGICAL, INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to SHOHRAT ANNABERDYEV, M.D.. To verify SHOHRAT ANNABERDYEV, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SHOHRAT ANNABERDYEV, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 181 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

181
Total Claims
$4K
Total Drug Cost
68
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
181
Total Day Supply
995
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$1K
Generic Drug Cost
$3K
Opioid Claims
47 (26.0% rate)
Antibiotic Claims
65

Patient Demographics

Average Patient Age
72.2 years
Avg HCC Risk Score
1.38
Gender Split
53% female / 47% male
Age Distribution
<65: 11, 65-74: 27, 75-84: 19, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SHOHRAT ANNABERDYEV, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
44
Metronidazole
32
Neomycin Sulfate
28
Gavilyte-G
"Peg3350/Sod Sulf
N/A
Sod Sulf-Potass Sulf-Mag Sulf
"Sodium
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Colon & Rectal Surgery Physician Overview

How SHOHRAT ANNABERDYEV, M.D. fits within the Colon & Rectal Surgery Physician landscape nationally.

1,608
Colon & Rectal Surgery Physician Providers in US
50
States with Colon & Rectal Surgery Physician
196
Avg Claims per Provider

SHOHRAT ANNABERDYEV, M.D.'s 181 claims are below the specialty average of 196.

Nearby Colon & Rectal Surgery Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ANNABERDYEV.

Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHOHRAT ANNABERDYEV, M.D.'s specialty?
SHOHRAT ANNABERDYEV, M.D. specializes in Colon & Rectal Surgery Physician and practices in ROSEVILLE, California. Credentials: M.D..
How much does SHOHRAT ANNABERDYEV, M.D. prescribe under Medicare Part D?
In 2023, SHOHRAT ANNABERDYEV, M.D. wrote 181 Medicare Part D claims totaling $4K in drug costs for 68 beneficiaries.
Where is SHOHRAT ANNABERDYEV, M.D. located?
SHOHRAT ANNABERDYEV, M.D. is located at 8 MEDICAL PLAZA DR STE 300, ROSEVILLE, CA, 95661. Phone: (916) 755-7095.
What is SHOHRAT ANNABERDYEV, M.D.'s NPI number?
SHOHRAT ANNABERDYEV, M.D.'s National Provider Identifier (NPI) is 1386888147, issued on 04/23/2009.
Does SHOHRAT ANNABERDYEV, M.D. prescribe more brand-name or generic drugs?
SHOHRAT ANNABERDYEV, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $1K in brand drug costs.
Does SHOHRAT ANNABERDYEV, M.D. prescribe opioids?
Yes, SHOHRAT ANNABERDYEV, M.D. had 47 opioid claims in 2023 with an opioid prescribing rate of 26.0%.
How many Colon & Rectal Surgery Physician providers are there in the US?
There are 1,608 Colon & Rectal Surgery Physician providers across 50 states in the US. The average Colon & Rectal Surgery Physician provider writes 196 Medicare Part D claims per year.
What drugs does SHOHRAT ANNABERDYEV, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SHOHRAT ANNABERDYEV, M.D.'s most frequently prescribed drugs include Oxycodone-Acetaminophen, Metronidazole, Neomycin Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHOHRAT ANNABERDYEV, M.D. accept Medicare?
SHOHRAT ANNABERDYEV, M.D. appears in CMS Medicare data with 181 Part D claims and 68 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHOHRAT ANNABERDYEV, M.D.'s credentials?
SHOHRAT ANNABERDYEV, M.D.'s NPI is 1386888147 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology